Tag: medulloblastoma research
Medulloblastoma drug effect only seen with molecular profiling
Modern molecular profiling of medulloblastomas recently highlighted a previously unrecognised treatment benefit in a major international clinical trial.
Molecular profiles show up clinical trial benefits
Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.
New breakthrough into Medulloblastoma
Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.
New insight into medulloblastoma
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.
Gene-editing techniques give new insight on key protein involved in medulloblastoma development
Researchers at St. Jude Children’s Research Hospital, USA have revealed how a key protein involved in driving the growth of the most aggressive form of medulloblastoma also plays a role in stopping its development.
American researchers explore cell enzyme as a potential paediatric brain tumour treatment
Researchers from the University of North Carolina Health Care System have been exploring the role of a DNA repair enzyme in cells called Dicer. When they removed this enzyme from preclinical models of medulloblastoma, a brain cancer often found in children, they found increased levels of DNA damage that led to the cell’s death.